Cano Health, Inc. CANOQ

0.24 0.00 0.00% as of 28 Jun
Market cap
$6.6M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23
P/E ratio
— 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 0.00 0.00 0.94 0.09 0.00
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00
P/Operating CF
— 0.00 9,795.16 (64.54) (3.95) (0.32)
P/B ratio
— 0.00 2,330.71 1.90 0.50 0.00
Price to Tangible BV
— 0.00 0.00 0.00 0.00 0.00
EV/Sales
— 0.00 0.00 1.42 0.47 (0.01)
EV/EBITDA
— 0.00 7,027.74 0.00 0.00 0.07
EV/Operating CF
— 0.00 (12,574.59) (19.41) (8.75) 0.19
EV/FCF
— 0.00 (5,450.15) (15.03) (6.54) 0.16
Quick Ratio
— 0.00 1.51 1.84 1.25 0.12
Current Ratio
— 0.00 1.65 1.97 1.63 0.13
Net Debt/EBITDA
— 0.00 18.62 (9.54) (53.56) 0.10
Debt/Assets
0.00% 0.00% 81.22% 43.61% 55.10% 5.45%
Debt/Equity
— 0.00 10.05 1.17 2.15 (0.10)
Asset Turnover
— 15,850.18 2.71 1.17 1.35 2.13
Operating CF/Net income
— 0.78 0.13 6.55 0.71 0.22
Capex/Depreciation
— (1.26) (0.48) (0.63) (0.12) (0.03)
Interest Coverage
— 0.00 0.00 0.00 0.00 0.00
ROE
— (79.12%) (286.43%) (4.25%) (32.06%) 2,919.11%
ROA
— (86,754.39%) (23.14%) (1.31%) (10.18%) (40.40%)
ROIC
— 0.00% (0.03%) (5.38%) (17.84%) 0.00%
Return on Tangible Assets
— 38,860.51% (86.70%) (7.46%) (78.62%) 50.46%
Average Days of Receivables
— 0.00 29.56 30.26 31.16 8.82
Research and Development Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
— 16.37% 12.50% 15.67% 15.42% 11.56%
Intangible Assets out of Total Assets
0.00 0.00 0.75 0.74 0.66 0.68
Share Based Compensation of Revenue
— 0.05% 0.06% 1.74% 2.00% 0.26%
Graham Net Nets
— 0.00 0.00 (0.68) (4.46) (94.83)
Graham Number
— 0.00 0.00 0.00 0.00 1,059.04
Earnings Yield
— 0.00% (0.03%) (2.27%) (77.68%) (4,906.41%)
Free Cash Flow Yield
— 0.00% (0.02%) (10.03%) (79.79%) (1,029.45%)
Revenue per Share
— 0.00 0.00 943.86 1,249.68 1,139.30
Operating CF per Share
— 0.00 0.00 (69.22) (66.77) (46.86)
Capex per Share
— 0.00 0.00 (20.15) (22.60) (6.98)
Free Cash Flow per Share
— 0.00 0.00 (89.37) (89.37) (53.84)
Cash per Share
— 0.00 0.00 95.70 12.47 34.10
Shareholders Equity per Share
— 0.00 0.00 468.34 225.52 (194.26)
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.00 0.00 468.34 225.52 (194.26)
Free Cash Flow
— (24.77) (21.31) (152.39) (195.87) (148.28)
Working Capital
— (0.05) 43.84 156.20 132.31 (1,232.60)
Capital Expenditures
— (9.31) (12.07) (34.35) (49.53) (19.23)
Net Current Asset Value
— (0.05) (453.55) (1,027.74) (1,093.90) (1,365.92)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.02
Capex to Sales
— 0.03 0.01 0.02 0.02 0.01
Net Profit Margin
— (5.47%) (8.55%) (1.12%) (7.57%) (18.94%)
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
— 0.00 0.66 0.64 3.18 11.61
Cash ROIC
— 291,792.45% (8.13%) (10.72%) (17.52%) 47.61%
Accounts Receivable Turnover
— 0.00 8.32 16.03 14.92 20.27
Accounts Payable Turnover
— — 0.00 0.00 0.00 0.00
Inventory Turnover
— — 0.00 0.00 0.00 —
Average Days of Payables
— — 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — 0.00 0.00 0.00 —
Average Receivables
— — 100.00 100.39 183.62 154.81
Average Payables
— — 52.00 56.10 93.28 107.04
Average Inventory
— — 1.00 0.96 — —
Average Assets
— 0.02 307.12 1,378.86 2,036.23 1,471.33
Average Common Equity
— 25.00 24.81 424.10 646.42 (20.36)

Fold the line items

Columns are period end dates